Neumeier Poma Investment Counsel LLC Buys 28,527 Shares of Huron Consulting Group Inc. $HURN

Neumeier Poma Investment Counsel LLC increased its holdings in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 11.7% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 272,845 shares of the business services provider’s stock after purchasing an additional 28,527 shares during the quarter. Huron Consulting Group accounts for about 3.5% of Neumeier Poma Investment Counsel LLC’s investment portfolio, making the stock its 8th largest holding. Neumeier Poma Investment Counsel LLC’s holdings in Huron Consulting Group were worth $37,527,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of HURN. CWM LLC raised its holdings in Huron Consulting Group by 55.9% in the first quarter. CWM LLC now owns 407 shares of the business services provider’s stock valued at $58,000 after acquiring an additional 146 shares in the last quarter. Victory Capital Management Inc. grew its holdings in shares of Huron Consulting Group by 13.2% during the first quarter. Victory Capital Management Inc. now owns 8,711 shares of the business services provider’s stock valued at $1,250,000 after purchasing an additional 1,019 shares during the last quarter. Allianz Asset Management GmbH bought a new position in shares of Huron Consulting Group during the first quarter valued at approximately $689,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Huron Consulting Group in the first quarter worth $3,055,000. Finally, KLP Kapitalforvaltning AS boosted its stake in Huron Consulting Group by 39.0% during the 1st quarter. KLP Kapitalforvaltning AS now owns 8,200 shares of the business services provider’s stock valued at $1,176,000 after purchasing an additional 2,300 shares during the period. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Huron Consulting Group in a research note on Wednesday, October 8th. Truist Financial raised their price objective on shares of Huron Consulting Group from $180.00 to $240.00 and gave the stock a “buy” rating in a research note on Friday, November 14th. Barrington Research lifted their price objective on shares of Huron Consulting Group from $173.00 to $176.00 and gave the stock an “outperform” rating in a research report on Thursday, August 7th. Benchmark increased their price objective on Huron Consulting Group from $165.00 to $180.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Finally, Wall Street Zen raised Huron Consulting Group from a “hold” rating to a “buy” rating in a research note on Saturday, November 1st. Six research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Huron Consulting Group presently has a consensus rating of “Buy” and a consensus price target of $190.25.

Huron Consulting Group Trading Up 0.3%

HURN stock opened at $161.00 on Wednesday. The business has a fifty day moving average price of $152.37 and a 200 day moving average price of $143.34. The stock has a market capitalization of $2.78 billion, a price-to-earnings ratio of 26.97 and a beta of 0.28. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.44 and a quick ratio of 1.99. Huron Consulting Group Inc. has a fifty-two week low of $116.77 and a fifty-two week high of $174.26.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings results on Tuesday, October 28th. The business services provider reported $2.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.24. Huron Consulting Group had a return on equity of 27.06% and a net margin of 6.54%.The business had revenue of $441.28 million for the quarter, compared to analyst estimates of $418.13 million. During the same quarter in the prior year, the firm posted $1.68 earnings per share. The firm’s revenue for the quarter was up 16.7% compared to the same quarter last year. Huron Consulting Group has set its FY 2025 guidance at 7.600-7.700 EPS. Analysts expect that Huron Consulting Group Inc. will post 6.1 EPS for the current fiscal year.

Insider Buying and Selling at Huron Consulting Group

In other news, Director James H. Roth sold 2,000 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $164.13, for a total value of $328,260.00. Following the sale, the director owned 37,304 shares of the company’s stock, valued at $6,122,705.52. The trade was a 5.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO James Ronald Dail sold 7,824 shares of the business’s stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $169.53, for a total value of $1,326,402.72. Following the transaction, the chief operating officer directly owned 31,184 shares in the company, valued at $5,286,623.52. This trade represents a 20.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 17,808 shares of company stock valued at $2,823,525. Company insiders own 2.15% of the company’s stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.